Position in EOLS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,469,114
+$10,337,457 QoQ
Shares Held
1,508,518
+18461.8% QoQ
Ownership
2.28%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#11
of 157 holders
Holding Since
Mar 2021
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names. EOLS ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
201,159 | $108,993,980 | |
| 2 | HLN |
Haleon plc
|
9,264,255 | $86,435,499 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
629,806 | $69,870,677 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,250,639 | $51,313,718 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
659,493 | $42,174,577 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,059,778 | $35,905,278 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
2,235,821 | $11,022,597 | |
| 8 | EOLS |
Evolus, Inc.
This page
|
1,508,518 | $10,469,114 |
All Filings in EOLS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,469,114 | 1,508,518 | Shares | Defined | 2026-08-14 | |
| 2024-09-30 | $131,657 | 8,127 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $2,746,800 | 196,200 | Shares | Defined | 2024-05-15 | |
| 2023-03-31 | $18,535 | 2,191 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $3,475,956 | 309,800 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,022,006 | 310,600 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $1,034,004 | 79,600 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||